Emergence of Extensively Drug-Resistant Neisseria gonorrhoeae, France, 2023.

IF 7.2 2区医学 Q1 IMMUNOLOGY

Emerging Infectious Diseases Pub Date : 2024-09-01 Epub Date: 2024-07-31 DOI:10.3201/eid3009.240557

François Caméléna, Manel Mérimèche, Julie Brousseau, Mary Mainardis, Pascale Verger, Caroll Le Risbé, Elise Brottet, Alexandra Thabuis, Cécile Bébéar, Jean-Michel Molina, Florence Lot, Emilie Chazelle, Béatrice Berçot

引用次数: 0

Abstract

Since 2022, Europe has had 4 cases of extensively drug-resistant Neisseria gonorrhoeae, sequence type 16406, that is resistant to ceftriaxone and highly resistant to azithromycin. We report 2 new cases from France in 2023 involving strains genetically related to the 4 cases from Europe as well as isolates from Cambodia.

查看原文本刊更多论文

2023 年法国出现广泛耐药的淋病奈瑟菌。

自2022年以来，欧洲出现了4例广泛耐药的淋病奈瑟菌病例，其序列类型为16406，对头孢曲松耐药，对阿奇霉素高度耐药。我们报告了2023年法国新增的2例病例，涉及的菌株与欧洲的4例病例以及柬埔寨的分离株在基因上有关联。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Emerging Infectious Diseases 医学-传染病学

CiteScore

17.30

自引率

1.70%

发文量

505

审稿时长

1 months

期刊介绍： Emerging Infectious Diseases is a monthly open access journal published by the Centers for Disease Control and Prevention. The primary goal of this peer-reviewed journal is to advance the global recognition of both new and reemerging infectious diseases, while also enhancing our understanding of the underlying factors that contribute to disease emergence, prevention, and elimination. Targeted towards professionals in the field of infectious diseases and related sciences, the journal encourages diverse contributions from experts in academic research, industry, clinical practice, public health, as well as specialists in economics, social sciences, and other relevant disciplines. By fostering a collaborative approach, Emerging Infectious Diseases aims to facilitate interdisciplinary dialogue and address the multifaceted challenges posed by infectious diseases.